FDA drug class
Orexin Receptor Antagonists list
Every FDA-approved prescription drug the FDA NDC directory tags with the Orexin Receptor Antagonist [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 3 single-ingredient drugs in this class: daridorexant, lemborexant, suvorexant.
Run it in Rivvi
Map Quviviq and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Orexin Receptor Antagonists (3)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Daridorexant | Quviviq | Single ingredient | 2 | Schedule IV |
| Lemborexant | Dayvigo | Single ingredient | 2 | Schedule IV |
| Suvorexant | Belsomra | Single ingredient | 4 | Schedule IV |
FDA established pharmacologic class: Orexin Receptor Antagonist [EPC].
Questions
What drugs are Orexin Receptor Antagonists?
The FDA NDC directory lists 3 single-ingredient drugs in this class: daridorexant, lemborexant, suvorexant.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.